Search - tctmd.com

Displaying 101 - 114 of 114

Sort: Relevancy | Date

News Daily News

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

April 19, 2013

News Daily News

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

April 12, 2013

News Daily News

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

April 12, 2013

Presentation

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Presenter: Michael D. Dake

April 10, 2013

Presentation

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Presenter: Antonio Micari

April 03, 2013

Presentation

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Presenter: T. Zeller

April 03, 2013

News Daily News

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

Caitlin E. Cox

December 09, 2012

News Daily News

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Caitlin E. Cox

December 09, 2012

Presentation

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Presenter: Michael Werk

December 06, 2012

News Daily News

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

August 07, 2012

News Daily News

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

August 07, 2012

Presentation

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

Presenter: S. Cassese

August 06, 2012

News Daily News

First DES for Above-the-Knee Vascular Disease on the Horizon

L.A. McKeown

October 18, 2011

News Daily News

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

January 17, 2011

Advertisement

Bailout DES Effective in CLI Patients with Below-the-Knee Lesions

Zilver PTX 2-Year Results Published: Superior Safety, Efficacy vs. Angioplasty Sustained

Resultado de 2 Años del Zilver PTX Publicados: Seguridad y Eficacia Superiores frente a Angioplastia Sostenida

Sustained Safety and Effectiveness of Paclitaxel-Eluting Stents for Femoropopliteal Lesions

Two-Year Results of Paclitaxel-Eluting Balloons (PEB) for Femoropopliteal Artery Disease

Treatment of Femoropopliteal In-Stent Restenosis with Paclitaxel-Eluting Stents

Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas

PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions

Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty

Meta-analysis: Paclitaxel-Coated Balloon Reduces TLR in Femoropopliteal Disease

Meta Análisis: El Balón Recubierto de Paclitaxel Reduce la RLD en la Enfermedad Femoropoplítea

Paclitaxel-Coated vs. Uncoated Balloon Angioplasty Reduces TLR in Femoropopliteal Disease

First DES for Above-the-Knee Vascular Disease on the Horizon

Zilver PTX: Novel DES for Femoropopliteal Disease Encouraging at 2 Years

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content